Moving Men’s Health Drugs from Prescription to Over-the-Counter with Fady Boctor Petros Pharmaceuticals TRANSCRIPT
Download PDFFeb 1, 2024
Fady Boctor, President and Chief Commercial Officer of Petros Pharmaceuticals, discusses the process of transitioning drugs from prescription to over-the-counter status, which includes conducting studies to determine label comprehension. In this situation, the FDA reviews the package wording to determine if the consumer can self-select the drug safely without a physician's involvement. With a focus on men's health issues like erectile dysfunction, Petros also sees the opportunity to educate consumers, reduce healthcare costs, and potentially identify related conditions that might require further investigation.
Fady explains, "Switches had been occurring, those prescriptions to OTC switches, have been occurring since really 1974, 1975. Over the past many years, about 106 products have been switched from prescription to OTC. The common denominator among those switches is that they're relatively safe products. We're talking antihistamines, allergy medications, and smoking cessation products. These are products that are relatively safe."
"We're trying to establish a new technology platform that speaks to transience and instantaneous engagement with the product. Imagine in a retail pharmacy aisle or at home on your mobile or desktop computer, you look at the product, engage with the drug facts label, and if you are appropriate for selection, use technology that supports your appropriate self-selection. You purchase the product as an OTC non-prescription, an amazing new frontier we're excited to be a part of."
"In 2022 or 2023, we're looking at roughly a 70,000 primary care physician shortage. By 2030, that's supposed to get into the triple digits of roughly 120,000 primary care physician shortages. We're already seeing it, where the waiting lists and the time to appointment are going into the weeks and months. Sometimes, these patients in a far more educated community with WebMD and the like, easily self-diagnosable conditions, should be actionable, with prescription medication switching to OTC to help meet that consumer where they need it and when they need it."
#PetrosPharma $PTPI #STENDRA #OTCSwitch #ErectileDysfunction #Avanafil
